...
首页> 外文期刊>Journal of investigative medicine >Suppressive Effects of Imidapril on Th1- and Th2-Related Chemokines in Monocytes.
【24h】

Suppressive Effects of Imidapril on Th1- and Th2-Related Chemokines in Monocytes.

机译:咪达普利对单核细胞中Th1和Th2相关趋化因子的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND:: Angiotensin-converting enzyme inhibitors (ACEIs) are used to control hypertension and are superior to other antihypertensive agents in protecting the progressive deterioration of autoimmune-related nephritis. An imbalance of T helper 1 (Th1)/Th2 is thought to contribute to the pathogenesis of autoimmune diseases and their related glomerulonephritis. I-309 is a Th2-related chemokine involved in the recruitment of Th2 cells toward Th2-related inflammation. Tumor necrosis factor alpha (TNF-alpha) and Th1-related chemokines, interferon-inducible protein 10 (IP-10)/CXCL10 are also involved in autoimmune glomerulonephritis. However, the modulatory effects and the mechanisms of ACEIs on TNF-alpha and Th1- and Th2-related chemokines in monocytes remain poorly defined. OBJECTIVE:: We investigated the effects of imidapril and perindopril, 2 ACEIs, on the expression of IP-10, I-309, and TNF-alpha in human monocytes and also the associated intracellular mechanism. RESULTS:: Imidapril and perindopril significantly downregulated lipopolysaccharide (LPS)-induced TNF-alpha, I-309, and IP-10 in THP-1 cells and human primary monocytes. All 3 mitogen-activated protein kinase inhibitors suppressed LPS-induced TNF-alpha and I-309 expression in human primary monocytes. Only extracellular signal-regulated kinases and c-Jun N-terminal kinases (JNK) mitogen-activated protein kinase inhibitors suppressed LPS-induced IP-10 expression. Lipopolysaccharide-induced mitogen-activated protein kinase kinase 4 (MKK4), p-JNK, and c-Jun expression in human primary monocytes was suppressed by imidapril. CONCLUSIONS:: These data demonstrate that ACEI is effective in downregulating LPS-induced TNF-alpha, I-309, and IP-10, which play important roles in the pathogenesis of inflammation. Its suppressive effect on TNF-alpha, I-309, and IP-10 may, at least in part, involve the down-regulation of LPS-induced MKK4-JNK-c-Jun expression.
机译:背景:血管紧张素转换酶抑制剂(ACEIs)用于控制高血压,在保护自身免疫性肾炎的逐步恶化方面优于其他降压药。 T辅助1(Th1)/ Th2的失衡被认为是自身免疫性疾病及其相关肾小球肾炎的发病机理。 I-309是Th2相关趋化因子,参与Th2细胞向Th2相关炎症的募集。肿瘤坏死因子α(TNF-alpha)和Th1相关趋化因子,干扰素诱导蛋白10(IP-10)/ CXCL10也参与了自身免疫性肾小球肾炎。但是,ACEIs对单核细胞中TNF-α和Th1和Th2相关趋化因子的调节作用和机制尚不清楚。目的:我们研究了咪达普利和培哚普利,2种ACEI对人单核细胞IP-10,I-309和TNF-α表达的影响以及相关的细胞内机制。结果:咪达普利和培哚普利显着下调了THP-1细胞和人类原代单核细胞中脂多糖(LPS)诱导的TNF-alpha,I-309和IP-10。所有3种促分裂原激活的蛋白激酶抑制剂均抑制LPS诱导的人原代单核细胞中TNF-α和I-309的表达。仅细胞外信号调节激酶和c-Jun N端激酶(JNK)丝裂原激活的蛋白激酶抑制剂抑制LPS诱导的IP-10表达。咪达普利可抑制脂多糖诱导的人原代单核细胞中丝裂原活化的蛋白激酶激酶4(MKK4),p-JNK和c-Jun的表达。结论:这些数据表明ACEI可有效下调LPS诱导的TNF-α,I-309和IP-10,它们在炎症的发病机理中起重要作用。它对TNF-α,I-309和IP-10的抑制作用可能至少部分涉及下调LPS诱导的MKK4-JNK-c-Jun表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号